Viewing nowBipito 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Bionex Co., Ltd.

MFDS item code 201308416 · Approved 2013.07.26 · Insurance code 643103640
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It is mainly used in adults at risk for myocardial infarction, stroke, vascular surgeries, angina, congestive heart failure, and patients with type 2 diabetes. Additionally, it contributes to lowering total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels while increasing HDL-cholesterol levels. This drug is also used as an adjunct to diet for pediatric patients with heterozygous familial hypercholesterolemia who have family history or other risk factors. Overall, it effectively aids in lowering the risk of cardiovascular diseases and hyperlipidemia.
Patients receiving atorvastatin, whether before or during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20mg or 40mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This medicine is administered in a dose range of 10 ~ 80mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. - Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10mg of this medicine once daily, and the recommended maximum dose is 20mg once daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goal. Adjustments should be made at intervals of 4 weeks or longer.
This medication may cause unusual muscle symptoms, so if muscle pain or weakness occurs, you should inform your doctor immediately. Particularly, if muscle-related enzyme levels greatly increase, you may need to discontinue this medication. If you have liver dysfunction or a history of liver disease, you must consult your doctor before using this medication. Women who are pregnant or may become pregnant should not take this medication, and proper contraception is advised during its use. Nursing mothers should also not use this medication. Children, especially those under 10 years of age, should not take this medication. Patients with a history of alcohol abuse or liver disease should exercise caution while using this medication. Elderly individuals have a higher risk of muscle-related side effects and should be particularly cautious when taking it. Drug interactions may occur when taken with other medications, so you must inform your doctor or pharmacist of any medications you are currently taking, especially with specific antibiotics, antifungals, HIV treatments, certain heart medications, antacids, and oral contraceptives. Regular liver function tests and muscle enzyme tests should be conducted during the use of this medication, and you should consult healthcare professionals if any unusual symptoms occur. There are no specific antidotes for overdose, so appropriate treatment should be provided according to the symptoms. This medication should be kept out of the reach of children and stored in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Bionex Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.